Identify key risk factors in anesthetic-related morbidity and mortality associated with intraoperative use of neuro-muscular blocking agents (NMBAs).
Describe the current practice of intraoperative monitoring of neuromuscular blockade.
Assess the incidence of postoperative residual neuro-muscular paralysis.
- ■ Determine factors potentially responsible for the variations in practice with regard to neuromuscular management and monitoring.
- ■ Recommend changes in practice designed to decrease residual neuromuscular block and improve patient safety.